A once-a-week shot from Australian scientists could spare people with Parkinson's the grind of taking pills several times a day.
The tiny, biodegradable gel sits under the skin and releases steady doses of two key medicines all week long, aiming for steadier symptom control, fewer side effects, and a much simpler routine. Early lab tests look safe and effective, and the team hopes to move into human trials soon.
Weekly Injectable Breakthrough for Parkinson's
A once-a-week injection could greatly ease life for the more than eight million people who live with Parkinson's disease by replacing the daily routine of swallowing multiple pills.
Researchers at the University of South Australia (UniSA) have designed a long-acting shot that supplies a steady, seven-day dose of levodopa and carbidopa, the two main medicines used to control Parkinson's symptoms.
Details of their work appear in the journal Drug Delivery and Translational Research.
Biodegradable Delivery System Cuts Pill Burden
The formulation, made from biodegradable materials, is injected just under the skin or into muscle. It then releases the medication gradually for an entire week.
Parkinson's disease is the world's second most common neurological condition, affecting more than 8.5 million people. Although no cure exists, tremors, stiffness, and slowed movement can be managed with oral drugs that often have to be taken several times a day.
This frequent dosing can be hard on patients, especially older adults or anyone who has trouble swallowing tablets. Irregular timing of doses causes uneven drug levels, extra side effects, and less dependable relief.
Researchers Highlight Life-Changing Potential
Lead researcher Professor Sanjay Garg, from UniSA's Centre for Pharmaceutical Innovation, says the newly developed injectable could significantly improve treatment outcomes and patient adherence.
"Our goal was to create a formulation that simplifies treatment, improves patient compliance, and maintains consistent therapeutic levels of medication. This weekly injection could be a game-changer for Parkinson's care," Prof Garg says.
"Levodopa is the gold-standard therapy for Parkinson's, but its short life span means it must be taken several times a day."
Steady Week-Long Release via Smart Polymer Gel
UniSA PhD student Deepa Nakmode says the in-situ implant is designed to release both levodopa and carbidopa steadily over one week, maintaining consistent plasma levels and reducing the risks associated with fluctuating drug concentrations.
"After years of focused research, it's incredibly rewarding to see our innovation in long-acting injectables for Parkinson's disease reach this stage. Our invention has now been filed for an Australian patent," Nakmode says.
The injectable gel combines an FDA-approved biodegradable polymer, PLGA, with Eudragit L-100, a pH-sensitive polymer, to achieve a controlled and sustained drug release.
Lab Results Show High Release and Safety
Extensive lab tests confirmed the system's effectiveness and safety:
- More than 90% of the levodopa dose and more than 81% of the carbidopa dose were released over seven days.
- The implant degraded by over 80% within a week and showed no significant toxicity in cell viability tests.
- The formulation can be easily administered through a fine 22-gauge needle, minimizing discomfort and eliminating the need for surgical implant.
Broader Impact and Path Toward Clinical Trials
"The implications of this research are profound," Prof Garg says. "By reducing the frequency of dosing from multiple times a day to a weekly injection is a major step forward in Parkinson's therapy. We're not just improving how the drug is delivered; we're improving patients' lives."
Prof Garg says the technology could also be adapted for other chronic conditions such as cancer, diabetes, neurodegenerative disorders, pain management, and chronic infections that require long-term drug delivery.
The system can be tuned to release drugs over a period ranging from a few days to several weeks depending on therapeutic needs.
UniSA scientists hope to start clinical trials in the near future and are exploring commercialization opportunities.
Reference: "Development of an in-situ forming implant system for levodopa and carbidopa for the treatment of parkinson's disease" by Deepa D. Nakmode, Sadikalmahdi Abdella, Yunmei Song and Sanjay Garg, 7 June 2025, Drug Delivery and Translational Research.
DOI: 10.1007/s13346-025-01892-y
News
Scientists Discover a New Form of Ice That Shouldn’t Exist
Researchers at the European XFEL and DESY are investigating unusual forms of ice that can exist at room temperature when subjected to extreme pressure. Ice comes in many forms, even when made of nothing but water [...]
Nobel-winning, tiny ‘sponge crystals’ with an astonishing amount of inner space
The 2025 Nobel Prize in chemistry was awarded to Richard Robson, Susumu Kitagawa and Omar Yaghi on Oct. 8, 2025, for the development of metal-organic frameworks, or MOFs, which are tunable crystal structures with extremely [...]
Harnessing Green-Synthesized Nanoparticles for Water Purification
A new review reveals how plant- and microbe-derived nanoparticles can power next-gen water disinfection, delivering cleaner, safer water without the environmental cost of traditional treatments. A recent review published in Nanomaterials highlights the potential of green-synthesized nanomaterials (GSNMs) in [...]
Brainstem damage found to be behind long-lasting effects of severe Covid-19
Damage to the brainstem - the brain's 'control center' - is behind long-lasting physical and psychiatric effects of severe Covid-19 infection, a study suggests. Using ultra-high-resolution scanners that can see the living brain in [...]
CT scan changes over one year predict outcomes in fibrotic lung disease
Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease progression and survival in [...]
AI Spots Hidden Signs of Disease Before Symptoms Appear
Researchers suggest that examining the inner workings of cells more closely could help physicians detect diseases earlier and more accurately match patients with effective therapies. Researchers at McGill University have created an artificial intelligence tool capable of uncovering [...]
Breakthrough Blood Test Detects Head and Neck Cancer up to 10 Years Before Symptoms
Mass General Brigham’s HPV-DeepSeek test enables much earlier cancer detection through a blood sample, creating a new opportunity for screening HPV-related head and neck cancers. Human papillomavirus (HPV) is responsible for about 70% of [...]
Study of 86 chikungunya outbreaks reveals unpredictability in size and severity
The symptoms come on quickly—acute fever, followed by debilitating joint pain that can last for months. Though rarely fatal, the chikungunya virus, a mosquito-borne illness, can be particularly severe for high-risk individuals, including newborns and older [...]
Tiny Fat Messengers May Link Obesity to Alzheimer’s Plaque Buildup
Summary: A groundbreaking study reveals how obesity may drive Alzheimer’s disease through tiny messengers called extracellular vesicles released from fat tissue. These vesicles carry lipids that alter how quickly amyloid-β plaques form, a hallmark of [...]
Ozone exposure weakens lung function and reshapes the oral microbiome
Scientists reveal that short-term ozone inhalation doesn’t just harm the lungs; it reshapes the microbes in your mouth, with men facing the greatest risks. Ozone is a toxic environmental pollutant with wide-ranging effects on [...]
New study reveals molecular basis of Long COVID brain fog
Even though many years have passed since the start of the COVID-19 pandemic, the effects of infection with SARS-CoV-2 are not completely understood. This is especially true for Long COVID, a chronic condition that [...]
Scientists make huge Parkinson’s breakthrough as they discover ‘protein trigger’
Scientists have, for the first time, directly visualised the protein clusters in the brain believed to trigger Parkinson's disease, bringing them one step closer to potential treatments. Parkinson's is a progressive incurable neurological disorder [...]
Alpha amino acids’ stability may explain their role as early life’s protein building blocks
A new study from the Hebrew University of Jerusalem published in the Proceedings of the National Academy of Sciences sheds light on one of life's greatest mysteries: why biology is based on a very specific set [...]
3D bioprinting advances enable creation of artificial blood vessels with layered structures
To explore possible treatments for various diseases, either animal models or human cell cultures are usually used first; however, animal models do not always mimic human diseases well, and cultures are far removed [...]
Drinking less water daily spikes your stress hormone
Researchers discovered that people who don’t drink enough water react with sharper cortisol spikes during stressful events, explaining why poor hydration is tied to long-term health risks. A recent study in the Journal of Applied [...]
Nanomed Trials Surge Highlighting Need for Standardization
Researchers have identified over 4,000 nanomedical clinical trials in progress now, highlighting rapid growth in the field and the need for a standardized lexicon to support clinical translation and collaboration. Nanotechnology is the science of [...]
